Data as of Sep 18
| +3.64 / +1.01%|
The 17 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 373.00, with a high estimate of 436.00 and a low estimate of 283.00. The median estimate represents a +2.83% increase from the last price of 362.74.
The current consensus among 19 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.